Cargando…
PROCALCITONIN AS A PREDICTOR OF CLINICAL OUTCOMES IN PATIENTS WITH COVID-19
Autores principales: | JACKSON, IAN, JARADEH, HADI, AURIT, SARAH, ALDAMEN, ALI, NARECHANIA, SHRADDHA, DESTACHE, CHRIS, VELAGAPUDI, MANASA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503304/ http://dx.doi.org/10.1016/j.chest.2021.07.528 |
Ejemplares similares
-
Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19
por: Jackson, Ian, et al.
Publicado: (2022) -
INCIDENCE, CLINICAL CHARACTERISTICS, AND OUTCOMES OF PATIENTS WITH COVID-19 AND FUNGAL COINFECTION
por: SWANEY, RICHARD, et al.
Publicado: (2022) -
ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022) -
COST ANALYSIS FOR USE OF PROCALCITONIN AND INFLAMMATORY MARKERS IN COVID-19 VENTILATOR-ASSOCIATED PNEUMONIA
por: KIM, A., et al.
Publicado: (2022) -
PATIENTS WITH MODERATE COVID-19: COMPARISON OF PROCALCITONIN SERUM LEVEL IN TWO GROUPS WITH DIFFERENT CHEST IMAGING FINDINGS
por: SHAFIEPOUR, M., et al.
Publicado: (2022)